Integrating Synthetic Biology with Hepatogenous Diabetes Treatments
Caleb Sooknanan ‘20 Hepatogenous diabetes is a condition often characterized by the comorbid presence of type 2 diabetes with chronic liver disease. A major factor in this condition is insulin resistance (IR), an asymptomatic disease state in which impaired insulin signaling causes organ dysfunction. Current therapies that target IR are limited and generally inapplicable for patients with liver disease. Dr. Shuai Xue and researchers at … Continue reading Integrating Synthetic Biology with Hepatogenous Diabetes Treatments

